Literature DB >> 15868611

Frequency of remissions in early rheumatoid arthritis defined by 3 sets of criteria. a 5-year followup study.

Heidi Mäkinen1, Hannu Kautiainen, Pekka Hannonen, Tuulikki Sokka.   

Abstract

OBJECTIVE: To study the frequency of remission using 3 sets of criteria in patients with rheumatoid arthritis (RA) at 5 years after the diagnosis.
METHODS: All adult patients with recent onset inflammatory arthritis who did not meet criteria or show clinical signs of other specific arthritides were included in the RA1997 inception cohort at Jyväskylä Central Hospital, Finland, and were assessed for remission at 5-year control examination. Remission was defined as (1) American College of Rheumatology (ACR) remission (fatigue excluded), (2) clinical remission with no tender and no swollen joints and normal erythrocyte sedimentation rate, and (3) radiographic remission with no worsening of erosions and no new erosions from baseline to 5 years.
RESULTS: The study included 127 patients with early RA (mean age 56 yrs, 61% female, 54% with positive rheumatoid factor, and 25% with erosions). At 5 years, 111 patients were examined, 17% (95% CI 11%-25%) of whom met ACR remission criteria, 37% (95% CI 28%-47%) met clinical remission criteria, and 55% (95% CI 49%-68%) met radiographic remission criteria. Only 13 (12%) patients met all 3 sets of remission criteria. The rate of remission was statistically significantly different (p < 0.001) using the 3 sets.
CONCLUSION: The rate of remission in RA depends on the criteria used. No gold standard exists for defining remission in RA. A set of criteria including no sign of inflammatory activity and no radiographic progression might be a basis for development of clinically relevant remission criteria for RA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15868611

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  Cost-effectiveness modeling of abatacept versus other biologic agents in DMARDS and anti-TNF inadequate responders for the management of moderate to severe rheumatoid arthritis.

Authors:  Anthony Russell; Ariel Beresniak; Louis Bessette; Boulos Haraoui; Proton Rahman; Carter Thorne; Ross Maclean; Danielle Dupont
Journal:  Clin Rheumatol       Date:  2008-12-17       Impact factor: 2.980

2.  Radiological damage in patients with rheumatoid arthritis on sustained remission.

Authors:  G Cohen; L Gossec; M Dougados; A Cantagrel; P Goupille; J P Daures; N Rincheval; B Combe
Journal:  Ann Rheum Dis       Date:  2006-08-25       Impact factor: 19.103

3.  Sex Differences in the Achievement of Remission and Low Disease Activity in Rheumatoid Arthritis.

Authors:  Carson Maynard; Ted R Mikuls; Grant W Cannon; Bryant R England; Philip G Conaghan; Mikkel Østergaard; Daniel G Baker; Gail Kerr; Michael D George; Jennifer L Barton; Joshua F Baker
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-03       Impact factor: 4.794

4.  Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?

Authors:  H Mäkinen; H Kautiainen; P Hannonen; T Sokka
Journal:  Ann Rheum Dis       Date:  2005-06-07       Impact factor: 19.103

5.  Sex: a major predictor of remission in early rheumatoid arthritis?

Authors:  K Forslind; I Hafström; M Ahlmén; B Svensson
Journal:  Ann Rheum Dis       Date:  2006-12-07       Impact factor: 19.103

6.  Treatment of rheumatoid arthritis with methotrexate in Congolese patients.

Authors:  J J Malemba; J M Mbuyi Muamba; J Mukaya; X Bossuyt; P Verschueren; R Westhovens
Journal:  Clin Rheumatol       Date:  2013-05-07       Impact factor: 2.980

Review 7.  Induction of remission in rheumatoid arthritis: criteria and opportunities.

Authors:  Guido Valesini; Manuela Di Franco; Francesca Romana Spinelli; Rossana Scrivo
Journal:  Rheumatol Int       Date:  2008-09-21       Impact factor: 3.580

8.  Remission makes its way to rheumatology.

Authors:  Tuulikki Sokka; Heidi Mäkinen
Journal:  Arthritis Res Ther       Date:  2010-07-14       Impact factor: 5.156

9.  Time to achieve remission determines time to be in remission.

Authors:  Lydia G Schipper; Jaap Fransen; Alfons A den Broeder; Piet L C M Van Riel
Journal:  Arthritis Res Ther       Date:  2010-05-20       Impact factor: 5.156

Review 10.  Treatment of rheumatoid arthritis: a global perspective on the use of antirheumatic drugs.

Authors:  Tuulikki Sokka; Minja Envalds; Theodore Pincus
Journal:  Mod Rheumatol       Date:  2008-04-25       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.